Search Results for: insurance

Surprising main obstacle to point-of-care stem cell commercialization by small clinics

There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically …

Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »

Korean stem cell clinic sued by patients in U.S. for fraud

CelltexRNL

For the first time to my knowledge, patients have sued a dubious stem cell clinic (RNL Bio) for fraud. As one stem cell expert has put it (see below), now there is “blood in the water”. RNL Bio of Korea has reportedly (hat tip to Leigh Turner) just been sued for fraud by patients related to stem …

Korean stem cell clinic sued by patients in U.S. for fraud Read More »

iPS cells and endangered species: a recipe to avoid extinction?

Stem cell-based regenerative medicine has the potential to help treat not only humans with injuries or illness, but also veterinary patients such as dogs and horses. Is it also possible that stem cell technology could prevent extinction of endangered species? A recent paper suggests this may be the case. The paper in question by a …

iPS cells and endangered species: a recipe to avoid extinction? Read More »

Many reasons why you should attend this year’s World Stem Cell Summit!

This year’s World Stem Cell Summit is looking to be an amazing meeting and I highly recommend that you attend. By going you can learn a great deal about stem cells whether you are a stem cell scientists or not. But in addition, the Summit offers the opportunity to learn a lot more including about …

Many reasons why you should attend this year’s World Stem Cell Summit! Read More »

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients

What will we define as a success for any given stem cell biotech? In academia, even if we do pre-clinical, translational kind of biomedical sciences, we still do not often think about what it takes to succeed in industry. Even if we very much want our research to make a difference for patients, do we …

The recipe for success for stem cell biotechs such as Geron, ACT, and ViaCyte: 3 key ingredients Read More »

Not ready for prime time: the three critical challenges for IPS cells

FaviconIPSCELL

If IPS cells are not ready for prime time, it is probably due to these three critical challenges for these amazing cells. TUMORIGENICITY Those of us who work with IPS cells are very excited about their potential for use in regenerative medicine therapies. One serious hurdle we have talked about in the past is tumorigenicity. …

Not ready for prime time: the three critical challenges for IPS cells Read More »